ArticleScientific reports2026
Enhancing aerosol delivery in asthma and COPD: a comparison of MDI, valved holding chamber, and DPI systems using functional respiratory imaging (FRI).
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective respiratory therapy relies heavily on inhaler device efficiency and patient technique. While device performance is well-documented in idealized induction ports, there remains a critical lack of data integrating patient-specific disease states to compare pressurized metered-dose inhaler (MDI) and valved holding chamber (VHC) efficiency against legacy dry powder inhaler (DPI) formulations. This study addresses this gap using Functional Respiratory Imaging (FRI) which combines high-resolution computed tomography (CT) scans with Computational Fluid Dynamics (CFD) to quantitatively assess aerosol deposition in asthma and Chronic Obstructive Pulmonary Disease (COPD) patient models. We evaluated the performance of MDIs alone and with various VHCs, against DPIs under optimal and sub-optimal inhalation profiles. Our results indicate that while MDIs alone require precise coordination, the addition of a VHC (AeroChamber Plus Flow-Vu) maintains high intrathoracic deposition and significantly minimizes oropharyngeal deposition, even with inhalation delays. Furthermore, the MDI/VHC combination demonstrated superior lung delivery compared to other tested VHCs and DPIs. Notably, the MDI/VHC system exhibited greater consistency across varying flow rates, whereas the DPIs tested showed higher sensitivity to sub-optimal maneuvers. Using FRI as tool for comparative inhaler assessment these results suggest that MDIs with appropriate VHCs provide the most consistent medication delivery for obstructive airway diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.